Urology

• 

  Publication Venue For

  • Digital tomosynthesis: a new technique for imaging nephrolithiasis. Specific organ doses and effective doses compared with renal stone protocol noncontrast computed tomography..  83:282-287. 2014
  • The UroLume stent revisited: the Duke experience..  82:933-936. 2013
  • Short-term functional outcomes and complications associated with transperineal template prostate mapping biopsy..  82:166-170. 2013
  • Symptomatic bilateral delayed partial ureteral obstruction after bilateral endoscopic correction of vesicoureteral reflux with dextranomer/hyaluronic acid polymer..  81:184-187. 2013
  • NADiA ProsVue prostate-specific antigen slope is an independent prognostic marker for identifying men at reduced risk of clinical recurrence of prostate cancer after radical prostatectomy..  80:1319-1325. 2012
  • Urinary diversion in patients with spinal cord injury in the United States..  80:1247-1251. 2012
  • Partial orchiectomy for bilateral synchronous testicular masses in a prepubescent boy: a case report..  80:1144-1146. 2012
  • Characteristics and outcomes of tumors arising from the distal nephron..  80:140-146. 2012
  • The effect of noise-cancelling headphones or music on pain perception and anxiety in men undergoing transrectal prostate biopsy..  79:32-36. 2012
  • Focusing on testosterone..  78:S476-S477. 2011
  • Indications and practice with androgen deprivation therapy..  78:S478-S481. 2011
  • New data, new paradigms for treating prostate cancer patients--VI: novel hormonal therapy approaches..  78:S494-S498. 2011
  • Targeting the androgen receptor--theory and practice..  78:S482-S484. 2011
  • Traditional approaches to androgen deprivation therapy..  78:S485-S493. 2011
  • Diagnosis, staging, and risk factors: SIU/ICUD Consensus Meeting on Germ Cell Tumors (GCT), Shanghai 2009..  78:S427-S434. 2011
  • Contemporary use of nephron-sparing surgery for children with malignant renal tumors at freestanding children's hospitals..  78:422-426. 2011
  • Editorial comment..  77:991. 2011
  • Analysis of urinary function using validated instruments and uroflowmetry after primary and salvage prostate cryoablation..  76:1258-1265. 2010
  • Editorial comment. Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131..  76. 2010
  • Editorial comment. Acute lower urinary tract symptoms after prostate brachytherapy with cesium-131..  76:1147. 2010
  • Role of vitamin D(3) as a sensitizer to cryoablation in a murine prostate cancer model: preliminary in vivo study..  76:764.e14-764.e20. 2010
  • Contemporary epidemiology and characterization of newborn males with prune belly syndrome..  76:44-48. 2010
  • Predicting success in the endoscopic management of pediatric vesicoureteral reflux..  76:195-198. 2010
  • Editorial comment..  75:1416-1417. 2010
  • Public survey and survival data do not support recommendations to discontinue prostate-specific antigen screening in men at age 75..  75:1122-1127. 2010
  • Changes in Gleason score grading and their effect in predicting outcome after radical prostatectomy..  74:1090-1093. 2009
  • Focal therapy for prostate cancer is a reasonable treatment option in properly selected patients..  74:726-730. 2009
  • Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?.  74:643-647. 2009
  • Nonoperative management of nonvascular grade IV blunt renal trauma in children: meta-analysis and systematic review..  74:579-582. 2009
  • Sacral neuromodulation in children with dysfunctional elimination syndrome: description of incisionless first stage and second stage without fluoroscopy..  73:641-644. 2009
  • Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen..  72:882-886. 2008
  • Urothelial sloughing with obstruction after laparoscopic cryoablation of small renal carcinoma in solitary kidney..  72:716.e1-716.e2. 2008
  • Can prostate-specific antigen and prostate-specific antigen velocity be used for prostate cancer screening in men older than 70 years?.  71:1020-1023. 2008
  • A prospective, randomized, double-blinded placebo-controlled comparison of extended release oxybutynin versus phenazopyridine for the management of postoperative ureteral stent discomfort..  71:792-795. 2008
  • Trainees do not negatively impact the institutional learning curve for robotic prostatectomy as characterized by operative time, estimated blood loss, and positive surgical margin rate..  71:597-601. 2008
  • Utility of dextranomer/hyaluronic acid injection in setting of bladder and ureteral anomalies..  71:435-438. 2008
  • A single-institution comparison between radical perineal and radical retropubic prostatectomy on perioperative and pathological outcomes for obese men: an analysis of the Duke Prostate Center database..  70:1146-1151. 2007
  • Prostate cancer in the Baby Boomer generation: results from CaPSURE..  70:1162-1167. 2007
  • Prostate cancer laterality does not predict prostate-specific antigen recurrence after radical prostatectomy..  70:1141-1145. 2007
  • Short-term cancer control after primary cryosurgical ablation for clinically localized prostate cancer using third-generation cryotechnology..  70:117-121. 2007
  • Tumor location does not affect long-term renal function after partial nephrectomy..  69:1059-1063. 2007
  • Ureteropelvic junction obliteration resulting in nephrectomy after radiofrequency ablation of small renal cell carcinoma..  69:982.e3-982.e5. 2007
  • Financial comparative analysis of minimally invasive surgery to open surgery for localized prostate cancer: a single-institution experience..  69:311-314. 2007
  • Multiple nephron-sparing procedures in solitary kidney with recurrent, metachronous, nonfamilial renal cell carcinoma..  68:1343.e1-1343.e3. 2006
  • Progression of renal tumors after laparoscopic radiofrequency ablation..  68:968-971. 2006
  • Outcomes of Gleason score 10 prostate carcinoma treated by radical prostatectomy..  68:604-608. 2006
  • Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality..  68:342-347. 2006
  • Is there a role for a low-carbohydrate ketogenic diet in the management of prostate cancer?.  68:15-18. 2006
  • Ovarian hyperstimulation causing ureteral obstruction in a pregnant woman..  67:1085.e5-1085.e6. 2006
  • Renal calculi presenting as hyperhidrosis in patient with spinal cord injury..  67:1084.e13-1084.e14. 2006
  • Use of Stone Cone minimizes stone migration during percutaneous nephrolithotomy..  67:1066-1068. 2006
  • Ureteral endometriosis in patients after total abdominal hysterectomy: presentation and diagnosis: a case series..  67:622.e13-622.e15. 2006
  • Percentage of positive biopsies associated with freedom from biochemical recurrence after low-dose-rate prostate brachytherapy alone for clinically localized prostate cancer..  67:349-353. 2006
  • Complications after percutaneous radiofrequency ablation of renal tumors..  66:1176-1180. 2005
  • Prostate-specific antigen versus prostate-specific antigen density as predictor of tumor volume, margin status, pathologic stage, and biochemical recurrence of prostate cancer..  66:1229-1233. 2005
  • Urorectal septum malformation sequence..  66:657. 2005
  • Lymphangioleiomyomatosis presenting as bladder outlet obstruction..  65:589-590. 2005
  • Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy?.  65:332-336. 2005
  • Ureteroscopic management of renal calculi in anomalous kidneys..  65:265-269. 2005
  • Heroic measures may not always be justified in extensive urethral stricture due to lichen sclerosus (balanitis xerotica obliterans)..  64:565-568. 2004
  • Impact of race on survival in men with metastatic hormone-refractory prostate cancer..  64:212-217. 2004
  • Management of nephropleural fistula after supracostal percutaneous nephrolithotomy..  64:241-245. 2004
  • Cancer control after low-dose-rate prostate brachytherapy performed by a multidisciplinary team with no previous prostate brachytherapy experience..  63:1128-1131. 2004
  • Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience..  63:746-750. 2004
  • Evolution of therapeutic approaches with luteinizing hormone-releasing hormone agonists in 2003..  62:20-28. 2003
  • Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy..  62:872-876. 2003
  • Ureteral reimplantation for inadvertent ureteral injury during radical perineal prostatectomy..  62:941. 2003
  • Prospective evaluation of pain medication requirements and recovery after radical perineal prostatectomy..  62:693-697. 2003
  • Serotonergic modulation of bladder afferent pathways..  62:10-15. 2003
  • Autoimmune testicular vasculitis..  61:1035. 2003
  • Liposarcoma presenting as an intraluminal ureteral mass..  61:1035. 2003
  • Clear cell adenocarcinoma in a female urethral diverticulum..  61:644. 2003
  • Intravesical liposome administration--a novel treatment for hyperactive bladder in the rat..  61:656-663. 2003
  • Intravesical protamine sulfate and potassium chloride as a model for bladder hyperactivity..  61:664-670. 2003
  • Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: the Center for Prostate Disease Research nomograms..  61:589-595. 2003
  • A structured literature review to determine the use of the American Society for Therapeutic Radiology and Oncology consensus definition of biochemical failure..  61:391-396. 2003
  • Aphallia with congenital urethrorectal fistula..  61:458-459. 2003
  • Management of small renal tumors with radiofrequency ablation..  61:23-29. 2003
  • Ruptured abdominal aortic aneurysm complicated by horseshoe kidney and renal cell carcinoma..  60:1108. 2002
  • Improved prostate cancer-specific survival and other disease parameters: impact of prostate-specific antigen testing..  60:756-759. 2002
  • Overview consensus statement. Newer approaches to androgen deprivation therapy in prostate cancer..  60:1-6. 2002
  • The role of androgen deprivation therapy combined with prostate brachytherapy..  60:39-44. 2002
  • Adult testicular sarcoma: presentation, evaluation, and treatment..  59:294-295. 2002
  • Relationship between obesity and race in predicting adverse pathologic variables in patients undergoing radical prostatectomy..  58:723-728. 2001
  • Use of serum creatinine to predict pathologic stage and recurrence among radical prostatectomy patients..  58:729-734. 2001
  • Plastibell template circumcision: a new technique..  58:603-604. 2001
  • Pilot study of dietary fat restriction and flaxseed supplementation in men with prostate cancer before surgery: exploring the effects on hormonal levels, prostate-specific antigen, and histopathologic features..  58:47-52. 2001
  • A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride..  57:112. 2001
  • Gene therapy of bladder pain with herpes simplex virus (HSV) vectors expressing preproenkephalin (PPE)..  57:116. 2001
  • Intravesical ultrapotent vanilloid receptor agonists: acute effects on animal models of bladder irritation..  57:111-112. 2001
  • Prostate-specific antigen-enhanced testing and risk stratification for chemoprevention trials..  57:174-177. 2001
  • A reliable, nondestructive animal model for interstitial cystitis: intravesical low-dose protamine sulfate combined with physiological concentrations of potassium chloride..  57:112. 2001
  • Intravesical ultrapotent vanilloid receptor agonists: acute effects on animal models of bladder irritation..  57:111-112. 2001
  • Removal of a UroLume prostatic stent using the holmium laser..  57:166-167. 2001
  • Impact of socioeconomic status and race on clinical parameters of patients undergoing radical prostatectomy in an equal access health care system..  56:1016-1020. 2000
  • Nitinol stone retrieval-assisted ureteroscopic management of lower pole renal calculi..  56:935-939. 2000
  • Prostate-specific antigen levels in young white and black men 20 to 45 years old..  56:812-816. 2000
  • Urethral polyp presenting in a male infant with hematuria and urinary retention..  54:921-922. 1999
  • Prostate cancer: demographic and behavioral correlates of stage at diagnosis among blacks and whites in North Carolina..  53:1194-1199. 1999
  • Management of 10-15-mm proximal ureteral stones: ureteroscopy or extracorporeal shockwave lithotripsy.  71:28-31.
  • Editorial comment..  80:1006. 2012
  • New data, new paradigms for treating patients with prostate cancer. Conclusion..  78:S499. 2011
  • New data, new paradigms for treating patients with prostate cancer: introduction..  78:S475. 2011
  • Editorial comment..  77:1152-1153. 2011
  • Editorial comment. Anticholinergics do not improve cure rate of alarm treatment of monosymptomatic nocturnal enuresis..  77:724-725. 2011
  • Editorial comment..  76:727. 2010
  • Editorial comment..  76:687. 2010
  • Editorial comment..  76:13-14. 2010
  • Editorial comment..  75:445-446. 2010
  • Editorial comment..  74:1221. 2009
  • Editorial comment. The value of intensive medical management of distal ureteral calculi in an effort to facilitate spontaneous stone passage..  56:582-583. 2000